BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33096077)

  • 21. The non-coding RNA llme23 drives the malignant property of human melanoma cells.
    Wu CF; Tan GH; Ma CC; Li L
    J Genet Genomics; 2013 Apr; 40(4):179-88. PubMed ID: 23618401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive genome-wide analysis of the long noncoding RNA expression profile in metastatic lymph nodes of oral mucosal melanoma.
    Ju H; Zhang L; Mao L; Wu Y; Liu S; Ruan M; Hu J; Ren G
    Gene; 2018 Oct; 675():44-53. PubMed ID: 29960071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
    Yu X; Zheng H; Tse G; Zhang L; Wu WKK
    Cell Prolif; 2018 Dec; 51(6):e12506. PubMed ID: 30094876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs.
    Honarmand Tamizkar K; Gorji P; Gholipour M; Hussen BM; Mazdeh M; Eslami S; Taheri M; Ghafouri-Fard S
    Front Immunol; 2021; 12():763323. PubMed ID: 34868009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of lncRNAs in autoimmune neuropathies.
    Gholipour M; Taheri M; Mehvari Habibabadi J; Nazer N; Sayad A; Ghafouri-Fard S
    Sci Rep; 2021 Aug; 11(1):16061. PubMed ID: 34373511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis.
    Ansari H; Shahrisa A; Birgani YT; Birgani MT; Hajjari M; Asl JM
    Pathol Oncol Res; 2019 Oct; 25(4):1387-1394. PubMed ID: 29948619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
    Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of long non-coding RNA and leukemia: A systematic review.
    Dieter C; Lourenco ED; Lemos NE
    Gene; 2020 Apr; 735():144405. PubMed ID: 32014562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
    Richtig G; Ehall B; Richtig E; Aigelsreiter A; Gutschner T; Pichler M
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNAs: Diverse roles in various disorders.
    Azizi Z; Mirtavoos-Mahyari H; Karimi R; Noroozi Z; Motevaseli E
    Hum Antibodies; 2019; 27(4):221-225. PubMed ID: 30909207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
    El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
    Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Non-coding RNAs and their Role in Metastasis.
    Weidle UH; Birzele F; Kollmorgen G; RĂ¼ger R
    Cancer Genomics Proteomics; 2017; 14(3):143-160. PubMed ID: 28446530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic study of novel lncRNAs in different gastrointestinal cancer cells.
    Cao B; Song N; Zhang M; Di C; Yang Y; Lu Y; Chen R; Lu ZJ; Guo M
    Discov Med; 2016 Mar; 21(115):159-71. PubMed ID: 27115166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of long non-coding RNAs in the pathogenesis of thyroid cancer.
    Ghafouri-Fard S; Mohammad-Rahimi H; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104332. PubMed ID: 31706987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
    Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
    Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
    Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
    Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.